Edge Capital Group, LLC Merck & Co., Inc. Transaction History

Edge Capital Group, LLC

$2.03 Billion
Q2 2024

A detailed history of Edge Capital Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Edge Capital Group, LLC holds 162,818 shares of MRK stock, worth $18.5 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

162,818

Previous 158,054 3.01%

Holding current value

$18.5 Million

Previous $20.9 Million 3.35%

% of portfolio

0.99%

Previous 1.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $589,783 - $633,421	4,764 Added 3.01%	162,818 $20.2 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $2.98 Million - $3.47 Million	26,330 Added 19.99%	158,054 $20.9 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $1.04 Million - $1.13 Million	10,365 Added 8.54%	131,724 $14.4 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $2.09 Million - $2.33 Million	-20,339 Reduced 14.35%	121,359 $12.5 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $36,818 - $40,130	339 Added 0.24%	141,698 $16.4 Million
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $2.3 Million - $2.57 Million	22,388 Added 18.82%	141,359 $15 Million
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $2.49 Million - $3.19 Million	28,458 Added 31.44%	118,971 $13.2 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $7.32 Million - $8.23 Million	86,648 Added 2241.86%	90,513 $7.8 Million
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $6.82 Million - $7.73 Million	-81,722 Reduced 95.48%	3,865 $651,000
Q1 2022 May 03, 2022	SELL	$73.51 - $82.4 $130,553 - $146,342	-1,776 Reduced 2.03%	85,587 $7.02 Million
Q4 2021 Jan 19, 2022	SELL	$72.28 - $90.54 $81,242 - $101,766	-1,124 Reduced 1.27%	87,363 $6.7 Million
Q3 2021 Oct 26, 2021	BUY	$71.68 - $78.83 $5.79 Million - $6.37 Million	80,812 Added 1052.93%	88,487 $6.65 Million
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $168,814 - $186,725	-2,401 Reduced 23.83%	7,675 $597,000
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $156,931 - $184,849	-2,279 Reduced 18.45%	10,076 $777,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $133,420 - $148,069	1,859 Added 17.71%	12,355 $1.01 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $85,620 - $97,051	1,170 Added 12.55%	10,496 $871,000
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $3,168 - $3,605	-45 Reduced 0.48%	9,326 $721,000
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $10,137 - $14,051	-160 Reduced 1.68%	9,371 $721,000
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $310 - $350	-4 Reduced 0.04%	9,531 $867,000
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $48,995 - $53,406	-644 Reduced 6.33%	9,535 $803,000
Q2 2019 Jul 25, 2019	BUY	$69.84 - $81.59 $43,161 - $50,422	618 Added 6.46%	10,179 $854,000
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $8,071 - $9,205	116 Added 1.23%	9,561 $795,000
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $616,191 - $715,080	9,445 New	9,445 $722,000

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Account

Edge Capital Group, LLC Merck & Co., Inc. Transaction History